• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » NIH Common Fund launches biomed programs

NIH Common Fund launches biomed programs

October 5, 2015
CenterWatch Staff

The NIH Common Fund has awarded more than $54 million in fiscal year 2015 to launch projects in four broad scientific areas: the Glycoscience Program, the 4D Nucleome Program, the Gabriella Miller Kids First Research Program and the Science of Behavior Change Program. The Common Fund planning process identifies major challenges that impede progress in research and emerging areas of science that promise to change the way people think about health and disease or the way prevention or treatment is approached. Common Fund programs that emerge are goal-driven, with deliverables expected within a five to 10 year period. The 2015 awards represented first-year funding of a multiyear program.

The Glycoscience Program is addressing the difficulty of studying proteins and lipids that have complex sugars attached, a problem that stymies researchers in virtually every arena of biomedical research. The program is led by the National Institute of General Medical Sciences and the National Institute of Dental and Craniofacial Research (NIDCR), and the awards are administered by several institutes and centers.

The 4D Nucleome Program is leveraging recent technological advances to transform understanding of gene regulation. The awards are being administered by the National Cancer Institute, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); the National Institute of Biomedical Imaging and Bioengineering; the National Heart, Lung and Blood Institute (NHLBI); and the National Institute on Drug Abuse (NIDA).

The Gabriella Miller Kids First Pediatric Research Program will develop a data resource for the pediatric research community of clinical and genetic sequence data that will allow scientists to identify genetic pathways that underlie structural birth defects and childhood cancer. The sequencing center grants are managed by the National Human Genome Research Institute.

The Science of Behavior Change Program aims to implement a mechanism-focused, experimental medicine approach to behavior change research. The network will receive about $7 million to fund a total of nine awards that are being administered by the National Institute on Aging, NIDA, the Eunice Kennedy Shriver National Institute of Child Health and Development, NHLBI, NIDDK, the National Center for Complementary and Integrative Health, the National Institute of Nursing Research, and NIDCR.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Revamp-360x240.png

    Califf Calls for Major Evidence Generation Revamp, Experts’ Opinions Differ

  • AskTheExpertsGreen-360x240.png

    Ask the Experts: Managing Investigational Products

  • SurveywBlueBackground-360x240.png

    Survey Outlines Site Challenges, Successes on Diversity

  • PatientCentricity-360x240.png

    Site Spotlight: DM Clinical Shows Patient Centricity Doesn’t Have to Break the Bank

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing